Skip to Main Content

Paper Details

Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
Inflamm Bowel Dis
0
2024
Author NameAffiliation
Sengwee TohHarvard Medical School and Harvard Pilgrim Health Care Institute
  • 1 - 1

Datasets

Release 1.2